YKL-40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma

Acta Paediatr. 2021 Feb;110(2):641-642. doi: 10.1111/apa.15525. Epub 2020 Sep 1.

Anna J James¹, Björn Nordlund^{2

3}, Jon R Konradsen^{2

3}, Christina Ebersjö^{4

5}, Sven-Erik Dahlén¹, Eva Berggren Broström^{4

5}, Gunilla Hedlin^{2

3}

¹ Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
² Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
⁵ Sach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.

No abstract available

Keywords: YKL-40; asthma; biomarker; bronchopulmonary dysplasia.

Publication types